The Genomic Characteristics of RET Fusion Positive Tumors in Chinese Non-Small Cell Lung Cancer (NSCLC) Patients
Guowu Wu(Meizhou City People's Hospital), Shifu Chen(Beike Biotechnology (China)), Longhua Guo(Jiaxing University), Tanxiao Huang(Beike Biotechnology (China)), Lilan Yi(Meizhou City People's Hospital), Xiaoni Zhang(Northern Kentucky University), Wenting Liao(China Pharmaceutical University), Junlin Zhu(Meizhou City People's Hospital), Dongdong Zhao(Wuhan University), Yan Yin(Nanjing University of Aeronautics and Astronautics), Ming Liu(Sun Yat-sen University), Yuanyuan Liu(Sun Yat-sen University), Bo Yang(Mellanox Technologies (Israel)), Ping Huang(Guangxi University), Yinfang Gu(Meizhou City People's Hospital), Xiaofang Zou
Cited by 1
Related Papers
Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer Therapy
|Journal of the American Chemical Society|2014|716
Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3
|Molecular Cancer|2019|647
Strategies for enhancing the sensitivity of plasmonic nanosensors
|Nano Today|2015|404
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
|JAMA|2024|359
Highly Uniform Gold Nanobipyramids for Ultrasensitive Colorimetric Detection of Influenza Virus
|Analytical Chemistry|2016|221